GeneGrafts

Cell Therapy for Modulating Excitable Tissues

Company Name
Updating Date
Neurotech Category
Market Category
Target Market
Technologies
Company Founded Year
Company Number of Employees
GeneGrafts
Biotechnology & Biopharmaceutical
01/01/2003
"1-10"

GeneGrafts Ltd is a biotechnology company developing proprietary technology for modulating excitable tissues, such as of the brain or heart, by cell therapy. This new paradigm can be used for treatment of various diseases including Parkinson's disease and other neurological disorders or cardiac arrhythmias.



The technology platform is based on transplantation of cell grafts, isolated from the patient's own body, which defines the ion channels. These grafted cells integrate functionally and structurally with the target organ, and their electrical properties are derived from the expressed ion channels. The electrical properties of the target organ are modulated in a predetermined way.Â